% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • rehdvm2004 rehdvm2004 Jan 10, 2013 6:53 PM Flag

    Olivier, Linazolid and subjects of interest to INSM Longs

    All Longs are hopeful that Lewis may have alluded to significant results with Arikace for NTM. That is the big issue and most important possibility for Arikace. I am hopeful that Arikace knocks out NTM in 30 days or less and that consecutive negative sputum cultures can be maintained for at least 60 days. That will be a breakthrough internationally.

    In searching Dr. Kenneth N Olivier, he is not only an expert ong NTM, he is an expert on TB. He has a 2012 paper on Linazolid that indicates it may be a breakthrough drug for multidrug resistent TB. Interested investors should do a PubMed (Medline) search on Kenneth N Olivier and look at his 26 publications. Just info to sort out all the paper pushing baloney on this MB from MMs trying to pump up or bash the stock. INSM is a definable entity in terms of the science, medicine and status among clinically investigated new drugs for infectious diseases.

    Again, your own DD is the most enlightening and the most accurate.

    Sentiment: Buy

11.06-0.11(-0.98%)Jul 22 4:00 PMEDT